PMID- 11730565 OWN - NLM STAT- MEDLINE DCOM- 20031104 LR - 20171116 IS - 1671-4083 (Print) IS - 1671-4083 (Linking) VI - 22 IP - 1 DP - 2001 Jan TI - Gene expression of monocyte chemoattractant protein-1 in human monocytes by exposure to advanced glycosylation end products. PG - 67-70 AB - AIM: To explore the effects of advanced glycosylation end products (AGEP) on monocyte chemoattractant protein-1 (MCP-1) gene expression in human peripheral blood monocytes/macrophages (PBMC). METHODS: Expression of MCP-1 mRNA in PBMC incubated with AGEP-bovine serum albumin (AGEP-BSA) was examined by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) with beta-actin as an internal standard. Sequencing of RT-PCR products was performed to confirm the specificity of amplification for MCP-1 gene. RESULTS: AGEP-BSA stimulated monocytes to express MCP-1 mRNA in a glucose-concentration-related fashion. The levels of MCP-1 mRNA were increased slightly when monocytes were exposed to AGEP-BSA 200 mg/L (glycosylated with glucose 20 mmol/L), and increased markedly when exposed to AGEP-BSA 200 mg/L (glycosylated with glucose 50 mmol/L), but decreased slightly when exposed to AGEP-BSA 200 mg/L (glycosylated with glucose 80 mmol/L). Expression of MCP-1 mRNA was undetectable in freshly isolated monocytes, but was induced at 12 h and reached a maximal level at 24 h and was almost undetectable at 36 h after the monocytes were incubated with AGEP-BSA 200 mg/L (P < 0.01). CONCLUSION: AGEP enhanced MCP-1 mRNA expression in human PBMC. FAU - Wang, B R AU - Wang BR AD - Division of Cardiology, The Zhong-Da Hospital and School of Clinical Medicine, Southeast University, Nanjing 210009, China. FAU - Liu, N F AU - Liu NF LA - eng PT - Journal Article PL - United States TA - Acta Pharmacol Sin JT - Acta pharmacologica Sinica JID - 100956087 RN - 0 (Chemokine CCL2) RN - 0 (Glycation End Products, Advanced) RN - 0 (RNA, Messenger) SB - IM MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis/genetics MH - Gene Expression/*drug effects MH - Glycation End Products, Advanced/*pharmacology MH - Humans MH - Monocytes/*drug effects/metabolism MH - RNA, Messenger/biosynthesis/genetics MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 2001/12/04 10:00 MHDA- 2003/11/05 05:00 CRDT- 2001/12/04 10:00 PHST- 2001/12/04 10:00 [pubmed] PHST- 2003/11/05 05:00 [medline] PHST- 2001/12/04 10:00 [entrez] PST - ppublish SO - Acta Pharmacol Sin. 2001 Jan;22(1):67-70.